Compare Hims and Hers Health Inc (HIMS) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs AT&T Inc. — how do they compare? Hims and Hers Health Inc trades at $28.34 (market cap $6.89B), while AT&T Inc. trades at $23.23 (market cap $167.68B). The key difference: AT&T Inc. is far larger — about 24.3× Hims and Hers Health Inc's market cap, and AT&T Inc. pays a 4.54% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and AT&T Inc. for 118 Days on average.
| HIMS | T | |
|---|---|---|
Market Cap | $6.89B | $167.68B |
Volume | 5,446,628 | 27,788,850 |
Sector | Health | Media |
52-Week High | $62.76 | $29.10 |
52-Week Low | $14.52 | $20.49 |
Typical Hold Time | 21 Days | 118 Days |
Enterprise Value | $7.60B | $313.00B |
Dividend Yield | — | 4.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.
The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.
AT&T (T) trades at $24.885, up 1.88% in the last session, with a bearish technical signal but strong fundamentals including a P/E of 8.08 and net income margin of 16.94%. Recent earnings beats and a $3 billion fiber deal with Corning highlight growth initiatives, while cash flow improved to $15.12B in 2025.
The stock offers value with a 4%+ dividend yield and analyst consensus price target of $27.61, but faces risks from high debt and competitive pressures. Upside depends on execution in fiber and wireless, while sentiment is mixed amid dividend sustainability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
